In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Myriad RBM Inc.

Division of Myriad Genetics Inc.
www.myraidrbm.com

Latest From Myriad RBM Inc.

Making The Most Of A Maturing Myriad Genetics

Five and a half years after its decision to spin off its pharmaceutical business and a year and a half away from having the US Supreme Court break its monopoly on BRCA gene testing, Myriad Genetics is no longer an exception among molecular diagnostics companies. It must find its way along a more crowded path.

Medical Device BioPharmaceutical

Option Deal Structure Works For Myriad As It Moves To Buy Crescendo

Having watched Crescendo Bioscience gain a foothold in the market for inflammatory and autoimmune diagnostics, Myriad Genetics is now moving to acquire the company – a right it obtained via a novel strategic investment agreement in 2011.

Medical Device

Option Deal Structure Works For Myriad As It Moves To Buy Crescendo

Having watched Crescendo Bioscience gain a foothold in the market for inflammatory and autoimmune diagnostics, Myriad Genetics is now moving to acquire the company – a right it obtained via a novel strategic investment agreement in 2011.

Medical Device Deals

Deals Shaping The Medical Industry, September 2013

Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
    • Pharmacogenetics-Pharmacogenomics
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
    • Molecular Diagnostics & Genetic Testing
  • Laboratory Testing Services
  • Services
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Rules-Based Medicine Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Myriad Genetics Inc.
  • Senior Management
  • T. Craig Benson, Pres. & CEO
    Patrick McClain, CFO
    Peter Amatulli, VP, Sales & Mktg.
    Ralph L McDade, PhD, Strategic Dev. Officer
    Samuel T LaBrie, PhD, VP, Corp. Dev.
  • Contact Info
  • Myriad RBM Inc.
    Phone: (512) 835-8026
    3300 Duval Rd.
    Austin, TX 78759
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register